Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 3/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.34 |
| ▸ | DOT1L | Q8TEK3 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.34 |
| ▸ | DPP4 | P27487 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.34 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.34 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.34 |
| ▸ | GAPDH | P04406 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | STAT6 | P42226 | 1/20 | 0.34 |
| ▸ | PI4KA | P42356 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.34 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.34 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18470928 | 1.00 | ADORA2A (0.36) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL19636517 | 0.90 | ADORA2A (0.36) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL19632727 | 0.90 | ADORA2A (0.36) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL19229288 | 0.88 | ADORA2A (0.35) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL881381 | 0.88 | ADORA2A (0.40) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL10149698 | 0.88 | ADORA2A (0.40) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL19229334 | 0.88 | ADORA2A (0.35) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL15682919 | 0.85 | ADORA2A (0.41) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL19632732 | 0.85 | ADORA2A (0.36) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 | |
| SCHEMBL19636433 | 0.85 | ADORA2A (0.36) | ADORA2AADORA3DOT1LSMN1; SMN2SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170037078-A1 | 2' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER | COCRYSTAL PHARMA, INC. (US) | 2017-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170037078-A1 | 2' -DISUBSTITUTED NUCLEOSIDE ANALOGS FOR TREATMENT OF THE FLAVIVIRIDAE FAMILY OF VIRUSES AND CANCER | HAVCR2, HCCS, NAMPT | ADORA2A 90/4885ADORA3 330/4885DOT1L 3696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.